stella
beta
Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF — Stella
Recruiting
Back to Acute on Chronic Liver Failure trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
France
Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie, Lyon, Auvergne-Rhône-Alpes
CHU Pontchaillou, Rennes
View full record on ClinicalTrials.gov